Viriplanin a, a new anthracycline antibiotic of the nogalamycin group i. Isolation, characterization, degradation reactions and biological properties

The Journal of Antibiotics

Volumn 39, Issue 9, 1986, Pages 1193-1204

  Hütter, Klaus ^a   Baader, Ekkehard ^a   Frobel, Klaus ^a   Zeeck, Axel ^a   Bauer, Klaus ^b   Gau, Wolfgang ^b   Kurz, Jürgen ^b   Schröder, Theo ^b   Wünsche, Christian ^b   Kari, Wolfgang ^b   Wendisch, Detlef ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NEW DRUG; NOGALAMYCIN; VIRIPLANIN A;

AMPULLARIELLA REGULARIS; ANIMAL EXPERIMENT; DOSE RESPONSE; DRUG ANALYSIS; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG RESPONSE; DRUG SCREENING; DRUG STABILITY; DRUG TOXICITY; FUNGUS; GRAM POSITIVE BACTERIUM; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFRARED SPECTROMETRY; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBCUTANEOUS DRUG ADMINISTRATION; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ACTINOMYCETALES; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BACTERIA; CARBOHYDRATES; CHEMISTRY; DRUG STABILITY; NAPHTHACENES; SIMPLEXVIRUS;

EID: 0022454118     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.7164/antibiotics.39.1193     Document Type: Article

References (15)

1. 1) Bauer, K.; W. Frommer, W. Kaufmann, D. Schmidt, T. Schroder & G. Streissle (Bayer): Antivirales Antibiotikum, Verfahren zu seiner Herstellung und seine therapeutische Verwendung. Ger. Offen. 2, 946, 523, June 19, 1981
2. 2) Arora, S. K.: Molecular structure, absolute stereochemistry, and interactions of nogalamycin, a DNA-binding anthracycline antitumor antibiotic. J. Am. Chem. Soc. 105: 1328— 1332, 1983
3. 3) Wiley, P. F.; R. B. Kelly, E. L. Caron, V. H. Wiley, J. H. Johnson, F. A. Mackellar & S. A. Mizsak: Structure of nogalamycin. J. Am. Chem. Soc. 99: 542–549, 1977
4. 4) Wiley, P. F.; D. W. Elrod, D. J. Houser & F. A. Richard: Structure-activity relationships of nogalamycin analogues. J. Med. Chem. 25: 560–567, 1982
5. 5) Iselin, B. & T. Reichstein: 2-Deoxy-L-fucose. Helv. Chim. Acta 27: 1200—1203, 1944
6. 6) Zeeck, A.: Lipomycine, III. Isolierung und Zuordnung der Methyl-2,6-didesoxy-D-ribo-hexoside. Liebigs Ann. Chem. 1975: 2079–2088, 1975
7. 7) Hudson, C. S.: The classification of anomers by the symbols α-D,α-L, β-D and β-L. Adv. Carbohydr. Chem. 3: 15–18, 1948
8. 8) Ishn, K.; Y. Nishimura, S. Kondo & H. Umezawa: Decilonitrose and 4-O-succinyl-L-diginose, sugar components of decilorubicin. J. Antibiotics 36: 454 — 456, 1983
9. 9) Schwöbel, W.: Die Prüfung chemischer Substanzen auf virostatische Eigenschaften mit Hilfe des Plaque-Tests. Arch. Ges. Virusforsch. 14: 99—112, 1963
10. 10) Rada, B. & J. Zavada: Screening-test for cytostatic and virostatic substances. Neoplasma 9: 57 — 65, 1961
11. 11) Ishii, K.; S. Kondo, Y. Nishimura, M. Hamada, T. Takeuchi & H. Umezawa: Decilorubicin, a new anthracycline antibiotic. J. Antibiotics 36: 451 — 453, 1983
12. 12) Kawai, H.; Y. Hayakawa, M. Nakagawa, K. Imamura, K. Tanabe, A. Shimazu, H. Seto & N. Otake: Arugomycin, a new anthracycline antibiotic. J. Antibiotics 36: 1569—1571, 1983
13. 13) Kawai, H.; Y. Hayakawa, M. Nakagawa, K. Furihata, H. Seto & N. Otake: The structure of arugomycin, a new anthracycline antibiotic. Part I. Structural elucidation of degradation products, AG1, AG2 and AG3. Tetrahedron Lett. 25: 1937–1940, 1984
14. 14) Kawai, H.; Y. Hayakawa, M. Nakagawa, K. Furihata, H. Seto & N. Otake: Studies on arugomycin, a new anthracycline antibiotic. Part II. Structural elucidation of arugomycin. Tetrahedron Lett. 25: 1941–1944, 1984
15. 15) Ishii, K.; Y. Nishimura, H. Naganawa, S. Kondo & H. Umezawa: The structure of decilorubicin. J. Antibiotics 37: 344–353, 1984